{"entity":{"type":"insider","cik":"0001550424","url":"/insider/0001550424","json_url":"/insider/0001550424.json","name":"Rothera Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":11,"first":"2013-06-27","last":"2023-12-04","span_basis":"filed_date"},"name_variants":[{"name":"Rothera Mark","source":"filing","n_filings":11,"first_seen":"2013-06-27","last_seen":"2023-12-04"}],"transactions":[{"id":8585519,"accession":"0001209191-23-057239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057239","line_url":"/filing/0001209191-23-057239#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47906.0,"shares_display":"47,906","price_per_share":0.4932,"price_display":"0.49","price_state":"stated","total_value":23627.2392,"total_display":"23,627.24","total_whole":"23,627","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-04","scope":"insider"},{"id":8585516,"accession":"0001209191-23-057239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057239","line_url":"/filing/0001209191-23-057239#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"Viracta Therapeutics, Inc.","issuer_ticker":"VIRX","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52094.0,"shares_display":"52,094","price_per_share":0.494,"price_display":"0.49","price_state":"stated","total_value":25734.436,"total_display":"25,734.44","total_whole":"25,734","shares_owned_after":52094.0,"shares_owned_after_display":"52,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-04","scope":"insider"},{"id":3049131,"accession":"0001179110-16-021121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-021121","line_url":"/filing/0001179110-16-021121#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.23,"price_display":"6.23","price_state":"stated","total_value":12460.0,"total_display":"12,460.00","total_whole":"12,460","shares_owned_after":5125.0,"shares_owned_after_display":"5,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-03","filed_date":"2016-03-07","scope":"insider"},{"id":8674623,"accession":"0001179110-15-005202","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-005202","line_url":"/filing/0001179110-15-005202#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10700.0,"shares_display":"10,700","price_per_share":76.64,"price_display":"76.64","price_state":"stated","total_value":820048.0,"total_display":"820,048.00","total_whole":"820,048","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-18","scope":"insider"},{"id":8772404,"accession":"0001179110-15-004896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-004896","line_url":"/filing/0001179110-15-004896#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":76.36,"price_display":"76.36","price_state":"stated","total_value":22908.0,"total_display":"22,908.00","total_whole":"22,908","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-13","scope":"insider"},{"id":8072537,"accession":"0001179110-15-003449","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001179110-15-003449","line_url":"/filing/0001179110-15-003449#line-10","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":73.49,"price_display":"73.49","price_state":"stated","total_value":808390.0,"total_display":"808,390.00","total_whole":"808,390","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-25","filed_date":"2015-02-25","scope":"insider"},{"id":8072527,"accession":"0001179110-15-003449","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-15-003449","line_url":"/filing/0001179110-15-003449#line-7","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":67.7,"price_display":"67.70","price_state":"stated","total_value":67700.0,"total_display":"67,700.00","total_whole":"67,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-24","filed_date":"2015-02-25","scope":"insider"},{"id":8072520,"accession":"0001179110-15-003449","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-003449","line_url":"/filing/0001179110-15-003449","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":65.40478260869565,"price_display":"65.40","price_state":"stated","total_value":1504310.0,"total_display":"1,504,310.00","total_whole":"1,504,310","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-23","filed_date":"2015-02-25","scope":"insider","n_lines":4},{"id":8800881,"accession":"0001179110-15-001180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-001180","line_url":"/filing/0001179110-15-001180#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":60.02,"price_display":"60.02","price_state":"stated","total_value":180060.0,"total_display":"180,060.00","total_whole":"180,060","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-22","scope":"insider"},{"id":8674142,"accession":"0001179110-15-001015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-001015","line_url":"/filing/0001179110-15-001015#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":58.67,"price_display":"58.67","price_state":"stated","total_value":134941.0,"total_display":"134,941.00","total_whole":"134,941","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-16","scope":"insider"},{"id":8451320,"accession":"0001179110-15-000943","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-000943","line_url":"/filing/0001179110-15-000943#line-5","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":58.62,"price_display":"58.62","price_state":"stated","total_value":70344.0,"total_display":"70,344.00","total_whole":"70,344","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-14","filed_date":"2015-01-15","scope":"insider"},{"id":8451307,"accession":"0001179110-15-000943","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-000943","line_url":"/filing/0001179110-15-000943","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":57.959411764705884,"price_display":"57.96","price_state":"stated","total_value":492655.0,"total_display":"492,655.00","total_whole":"492,655","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-13","filed_date":"2015-01-15","scope":"insider","n_lines":2},{"id":6395472,"accession":"0001104659-14-068636","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-14-068636","line_url":"/filing/0001104659-14-068636#line-8","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":46.9,"price_display":"46.90","price_state":"stated","total_value":140700.0,"total_display":"140,700.00","total_whole":"140,700","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-26","filed_date":"2014-09-26","scope":"insider"},{"id":6395470,"accession":"0001104659-14-068636","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-14-068636","line_url":"/filing/0001104659-14-068636","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10100.0,"shares_display":"10,100","price_per_share":44.37871287128713,"price_display":"44.38","price_state":"stated","total_value":448225.0,"total_display":"448,225.00","total_whole":"448,225","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-25","filed_date":"2014-09-26","scope":"insider","n_lines":2},{"id":6395456,"accession":"0001104659-14-068636","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-14-068636","line_url":"/filing/0001104659-14-068636","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":43.184137931034485,"price_display":"43.18","price_state":"stated","total_value":125234.0,"total_display":"125,234.00","total_whole":"125,234","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-24","filed_date":"2014-09-26","scope":"insider","n_lines":2},{"id":7026369,"accession":"0001104659-14-066646","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-14-066646","line_url":"/filing/0001104659-14-066646","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":36.2387,"price_display":"36.24","price_state":"stated","total_value":289909.6,"total_display":"289,909.60","total_whole":"289,910","shares_owned_after":18840.0,"shares_owned_after_display":"18,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-16","scope":"insider","n_lines":3},{"id":5526843,"accession":"0001104659-13-052054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-052054","line_url":"/filing/0001104659-13-052054#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001550424","owner_name":"Rothera Mark","owner_display_name":"Rothera Mark","owner_url":"/insider/0001550424","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","total_whole":"375,000","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-25","filed_date":"2013-06-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"Viracta Therapeutics, Inc.","url":"/issuer/0001061027","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2023-12-04","last_seen":"2023-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Officer (Chief Commercial Officer)","n_filings":10,"first_seen":"2013-06-27","last_seen":"2016-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001550424","retrieved_at":"2026-08-22T18:39:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}